Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures

Laboratory Investigation

Volumn 84, Issue 1, 2004, Pages 138-145

  Hervás, Isabel ^a   Arnau, Miguel A ^a   Almenar, Luís ^a   Pérez Pastor, Jose L ^a   Chirivella, Melitina ^a   Osca, Joaquín ^a   Bello, Pilar ^a   Osa, Ana ^a   Martí, Jose F ^a   Vera, Francisco ^a   Mateo, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Creatinine; Diagnosis; Graft rejection; Hemodynamics; Natriuretic peptides; Radioimmunometric assay

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE; HUMAN; LABORATORY TEST; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; BIOPSY; BLOOD; ENDOCARDIUM; GRAFT REJECTION; HEART MUSCLE; HEMODYNAMICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REFERENCE VALUE; ROC CURVE; TIME;

ADOLESCENT; ADULT; AGED; BIOPSY; CREATININE; ENDOCARDIUM; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; REFERENCE VALUES; ROC CURVE; TIME FACTORS;

EID: 85047691133     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700011     Document Type: Article

References (45)

1. Ciliberto GR. Doppier echocardiography after heart transplantation. Ital Heart J 2000;11(Suppl):1411-1416.
2. Stengel SM, Allemann Y, Zimmerli M, et al. Doppier tissue imaging for assessing left ventricular diastolic dysfunction in heart transplant rejection. Heart 2000;86:432-437.
3. Puig M, Ballester M, Matias-Guiu X, et al. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. J Nucl Cardiol 2000;7:132-139.
4. Bello P, Almenar L, Marti JF, et al. Evaluation of the usefulness of the antimyosin monoclonal antibody (AMA) uptake in the diagnosis of heart transplant (HT) rejection. Rev Esp Med Nucl 1999;18:190-196.
5. Marie PY, Angioi M, Carteaux JP, et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001;37:825-831.
6. Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
7. Kambayashi Y, Nakao K, Mukoyama M, et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 1990;259:341-345.
8. Lang CC, Coutie WJ, Khong TK, et al. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens 1991;9:779-782.
9. Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide. Endocrinology 1992;130:229-239.
10. Wambach G, Koch J. BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. Clin Exp Hypertens 1995;17:619-629.
11. Florkowski CM, Richards AM, Espiner EA, et al. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 1994;266:R1244-R1250.
12. Jensen KT, Carstens J, Pedersen EB. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 1998;274:F63-F72.
13. Sagnella G. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998;95:519-529.
14. Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med 1999;134:437-444.
15. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart Production in the ventricle. Hypertension 1991;17:1152-1155.
16. Nakamura S, Naruse M, Naruse K, et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocites. Am J Hypertens 1991;4:909-912.
17. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
18. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-1412.
19. Clerico A, Iervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans. Horm Metab Res 1999;31:487-498.
20. Osca J, Quesada A, Arnau MA, et al. Péptido cerebral natriurético. Valor diagnostico en la insuficiencia cardíaca. Rev Esp Cardiol 2002;55:7-15.
21. Hervas I, Osca J, Perez-Pastor JL, et al. Radioimmunometric assay of natriuretic peptide type-B (BNP) in heart failure. Nucl Med. Commun 2003;24:61-69.
22. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
23. Sirgurdsson A, Swedberg K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am Heart J 1996;132:229-234.
24. Richards AM, Nicholls MG, Yandle TG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 1999;81:114-120.
25. de Lemos J, Morrow D, Bentley J, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021.
26. Sabatine M, Morrow D, de Lemos J, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105:1760-1763.
27. Ishizaka Y, Yamamoto Y, Fukunaga T, et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994;24:461-472.
28. Ationu A, Burch M, Singer D, et al. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 1993;27:188-191.
29. El Gamel A, Yonan NA, Keevil B, et al. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg 1997;63:1095-1100.
30. Buckley MG, Yacoub MH, Singer DR. Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients. J Hum Hypertens 1998;12:825-826.
31. Masters R, Davies R, Vainot J, et al. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287-291.
32. Almenar L, Hervas I, Martinez-Dolz L, et al. The value of brain natriuretic peptide for the diagnosis of heart transplant rejection. Transplant Proc 2002;34:174-175.
33. Billingham ME, Carry NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group: The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-593.
34. Izrailtyan I, Kresh JY, Morris RJ, et al. Early detection of acute allograft rejection by linear and noninvasive analysis of heart rate variability. J Thorac Cardiovasc Surg 2000;120:737-745.
35. 111Inlabelled lymphocytes and gamma scintigraphy. Circulation 1996;94:II-298-II-303.
36. Hausmann B, Muurling S, Stauch C, et al. Detection of diastolic dysfunction: acoustic quantification (AQ) in comparison to Doppler echocardiography. Int J Card Imaging 1997;13:301-310.
37. Bhatia SJ, Kirshenbaum JM, Shemin RJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 1987;76:819-826.
38. Park M, Scott R, Uber P, et al. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 2000;90:1326-1329.
39. Ationu A, Sorensen K, Whitehead B, et al. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children. A three-year follow up. Cardiovasc Res 1993;27:2135-2139.
40. Akiba T, Tachibana K, Togashi K, et al. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995;44(Suppl 1):S61-S64.
41. Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc. 2001;76:1111-1119.
42. Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001;59:1559-1566.
43. Florkowski CM, Richards AM, Espiner EA, et al. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 1994;266:R1244-R1250.
44. Yu CM, Sanderson JE, Shum IO, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996;17:1694-1702.
45. Lang CC, Prasad N, McAlpine HM, et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994;127:1635-1636.